Transcarent is a provider of a healthcare platform that facilitates improved outcomes and cost-effective decisions.
Transcarent has raised $481.0M in total funding. The most recent round was Series D. The last funding was announced in April 2025.
Transcarent's investors include General Catalyst, Kleiner Perkins, GreatPoint Ventures, Human Capital, Geodesic Capital.
Transcarent is headquartered in San Francisco, United States.
Transcarent is a provider of a healthcare platform that facilitates improved outcomes and cost-effective decisions.
Transcarent is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Transcarent — Funding & Investors." VCBacked, April 8, 2025, https://www.vcbacked.co/company/transcarent. Accessed July 19, 2026.
VCBacked. (2025). Transcarent — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/transcarent
{{cite web |title=Transcarent — Funding & Investors |url=https://www.vcbacked.co/company/transcarent |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated